Upgrade to SI Premium - Free Trial

Kezar Life Sciences (KZR)

7.29 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/13/26 *Est.)

Latest Headlines

Form 15-12G Kezar Life Sciences, May 21, 2026 6:04 AM - SEC Filing Form EFFECT Kezar Life Sciences, May 15, 2026 6:34 AM - SEC Filing Form SCHEDULE 13D/A Kezar Life Sciences, Filed by: TANG CAPITAL MANAGEMENT LLC May 13, 2026 4:15 PM - SEC Filing Form SCHEDULE 13G/A Kezar Life Sciences, Filed by: Baselake Partners, LP May 12, 2026 5:18 PM - SEC Filing Form SCHEDULE 13G/A Kezar Life Sciences, Filed by: BML Investment Partners, L.P. May 12, 2026 4:44 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: Schiller Mark C. May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: Wallace Courtney May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: Klearman Micki May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: Kauffman Michael May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: Kirk Christopher J. May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: COOPER GRAHAM K May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: BERGER FRANKLIN M May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: Garner Elizabeth May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: Fowler John Franklin May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: Belsky Marc May 11, 2026 4:31 PM - SEC Filing Form 4 Kezar Life Sciences, For: May 11 Filed by: Chiang Pichi Luo May 11, 2026 4:31 PM - SEC Filing Form S-8 POS Kezar Life Sciences, May 11, 2026 4:12 PM - SEC Filing Form S-8 POS Kezar Life Sciences, May 11, 2026 4:12 PM - SEC Filing Form S-8 POS Kezar Life Sciences, May 11, 2026 4:12 PM - SEC Filing Form S-8 POS Kezar Life Sciences, May 11, 2026 4:12 PM - SEC Filing Form S-8 POS Kezar Life Sciences, May 11, 2026 4:12 PM - SEC Filing Form S-8 POS Kezar Life Sciences, May 11, 2026 4:12 PM - SEC Filing Form S-8 POS Kezar Life Sciences, May 11, 2026 4:12 PM - SEC Filing Form S-8 POS Kezar Life Sciences, May 11, 2026 4:11 PM - SEC Filing Form POS AM Kezar Life Sciences, May 11, 2026 4:06 PM - SEC Filing Form 25-NSE Kezar Life Sciences, Filed by: Nasdaq Stock Market LLC May 11, 2026 10:46 AM - SEC Filing Form 8-K Kezar Life Sciences, For: May 08 May 11, 2026 9:30 AM - SEC Filing Form SC 14D9/A Kezar Life Sciences, Filed by: Kezar Life Sciences, Inc. May 11, 2026 9:28 AM - SEC Filing Form SC TO-T/A Kezar Life Sciences, Filed by: Aurinia Pharmaceuticals Inc. May 11, 2026 9:15 AM - SEC Filing Form 10-Q Kezar Life Sciences, For: Mar 31 May 11, 2026 6:06 AM - SEC Filing Form 10-K/A Kezar Life Sciences, For: Dec 31 April 30, 2026 4:22 PM - SEC Filing Form SC 14D9 Kezar Life Sciences, Filed by: Kezar Life Sciences, Inc. April 14, 2026 6:04 AM - SEC Filing Form SC TO-T Kezar Life Sciences, Filed by: Aurinia Pharmaceuticals Inc. April 13, 2026 7:28 AM - SEC Filing Shareholder Alert: Ademi LLP investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders April 7, 2026 7:28 AM - StreetInsider Form SCHEDULE 13G Kezar Life Sciences, Filed by: Baselake Partners, LP April 6, 2026 9:29 PM - SEC Filing Form SC14D9C Kezar Life Sciences, Filed by: Kezar Life Sciences, Inc. April 3, 2026 4:59 PM - SEC Filing Form 8-K Kezar Life Sciences, For: Apr 01 April 3, 2026 4:49 PM - SEC Filing Form SCHEDULE 13D/A Kezar Life Sciences, Filed by: TANG CAPITAL MANAGEMENT LLC April 1, 2026 4:15 PM - SEC Filing Jefferies on Kezar Life Sciences (KZR): acquisition 'valuation makes sense' March 30, 2026 3:52 PM - StreetInsider Form SC14D9C Kezar Life Sciences, Filed by: Kezar Life Sciences, Inc. March 30, 2026 8:36 AM - SEC Filing Form 8-K Kezar Life Sciences, For: Mar 30 March 30, 2026 8:33 AM - SEC Filing Aurinia to acquire Kezar Life Sciences for $6.955 per share plus CVR March 30, 2026 8:01 AM - StreetInsider Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right March 30, 2026 8:00 AM - BizWire Kezar Life Sciences (KZR) Halted, News Pending March 30, 2026 7:59 AM - StreetInsider Form 10-K Kezar Life Sciences, For: Dec 31 March 27, 2026 4:16 PM - SEC Filing Form 8-K Kezar Life Sciences, For: Mar 06 March 12, 2026 9:12 AM - SEC Filing Enodia Therapeutics acquires Kezar's Sec61 preclinical assets for $127M March 12, 2026 9:00 AM - StreetInsider Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences March 12, 2026 9:00 AM - BizWire Full Article List